Download PDF
1 / Pages

Other users also viewed these articles

What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease? Ingrid Rivera-Iñiguez; Arturo Panduro; Sonia Roman; Karina González-Aldaco;
Ann Hepatol. 2023;28:
The burden of liver disease in Latin America Luis Antonio Díaz; Marcela Villota-Rivas; Francisco Barrera; Jeffrey V. Lazarus; Marco Arrese;
Ann Hepatol. 2024;29:
Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis? Luciana Agoglia; Ana Carolina Cardoso; Lívia Barbosa; Cecília Schubert Xavier Lagalhard Victer; Sueli Carneiro; Paulo Henrique Condeixa de França; Maria Chiara Chindamo; Cristiane Alves Villela-Nogueira;
10.1016/j.aohep.2024.101477